Background and aims Toxoplasmic retinochoroiditis may recur months or years after the primary infection. Rupture of dormant cysts in the retina is the accepted hypothesis to explain recurrence. Here, the authors present evidence supporting the presence of Toxoplasma gondii in the peripheral blood of immunocompetent patients. Methods Direct observation by light microscopy and by immunofluorescence assay was performed, and results were confirmed by PCR amplification of parasite DNA. Results The authors studied 20 patients from Erechim, Brazil, including acute infected patients, patients with recurrent active toxoplasmic retinochoroiditis, patients with old toxoplasmic retinal scars, and patients with circulating IgG antibodies against T gondii and absence of ocular lesions. Blood samples were analysed, and T gondii was found in the blood of acutely and chronically infected patients regardless of toxoplasmic retinochoroiditis.
INTRODUCTION
Toxoplasma gondii is an obligate intracellular protozoan parasite and an important causative agent of human infection, worldwide. 1e3 In the immunocompetent host, the infection either may be asymptomatic, causing no more than a flu-like syndrome, or may lead to more severe symptoms such as uveitis, pneumonia, pericarditis, myositis and neurological disorders. 4 Uveitis is the most common lesion caused by T gondii in immunocompetent individuals, whereas encephalitis is most commonly seen in immunocompromised individuals. 1 Toxoplasmic retinochoroiditis, the infection caused by T gondii that affects many organs but mainly the eyes, may occur either immediately or long after initial infection, 2e4 and may be congenital or acquired after birth. 2e6 The pathogenesis of recurrent retinochoroiditis is controversial. Rupture of cysts can release viable parasites that induce necrosis and inflammation. Alternatively, retinochoroiditis might result from a hypersensitivity reaction triggered by unknown causes. 7 8 Recurrences of ocular lesions usually develop at the border of old scars and are attributed to rupture of tissue cysts located within the old lesions. The rupture may be triggered either by changes in the parasite metabolism or by the host immune response.
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A new active infection may be caused either by previous lesions in the brain or eyes carrying tissue cysts that have erupted or by reinfection. 10 12 To further understand the modus operandi and transmission of this parasitic infection, we previously genotyped the parasite's DNA from peripheral blood mononuclear cells (PBMC) collected from infected patients. 13 During PBMC separation, we incidentally observed tachyzoite-like organisms in cell suspensions. Although T gondii has been isolated from the blood of patients with acute infection, 14 15 its presence has not been described in the blood of immunocompetent patients with chronic infection. To investigate whether or not T gondii is present in the blood of patients, we designed a single blind study in which 20 consecutive patients who were evaluated at the Ophthalmology Clinic for putative ocular toxoplasmosis were included. Ten additional patients were later evaluated: six with active lesions and four IgG-positive IgM-negative patients who had no ocular symptoms. Our findings show that parasitaemia is present in patients with either acute or chronic toxoplasmosis, regardless of the presence of ocular disease.
METHODS

Study population
An observational study was performed to identify the presence of T gondii in the blood of 20 subjects from Erechim, Southern Brazil. The mean age was 39 years (range 12e68 years). All samples were blindly analysed; the clinical status and diagnosis of each patient were revealed only after laboratory analysis was finished. Diagnosis was established according to the criteria published elsewhere. 6 All patients were negative for syphilis (VDRL), tuberculosis (PPD) and HIV infection (ELISA). They were also negative for other differential diagnosis such as autoimmune diseases, as indicated by the patient's history, the clinical course of disease and/or lack of laboratory markers. 2 8 16 Initially, 20 patients were classified into five groups, based on serological test results and on the presence or absence of retinal lesions (table 1) . Patients with recently acquired ocular toxoplasmosis presented with circulating anti-T gondii IgM antibodies and a normal ocular exam. A retinochoroidal toxoplasmic scar in patients with IgG and without circulating IgM to T gondii was associated with inactive disease (group 3, n¼3). Patients with circulating anti-T gondii IgG and normal eye exam (group 4, n¼3), and those with no serological evidence of T gondii infection (T gondii-IgM and IgG negatives) and normal eye exam (group 5, n¼4) were used as control. Ten more patients were later included in the study, six in group 2 and four in group 3. Anti-T gondii IgG and IgM antibodies were assayed by ELISA (BioMèrieux, Marcy-l, Etoile, France) according to the manufacturer 's instructions. This study was approved by the ethics committee of the institutions involved. Blood was drawn after a written informed consent was obtained from each patient.
Detection of T gondii by light microscopy
Peripheral blood was obtained from the 28 subjects and blindly evaluated in the laboratory. The presence of tachyzoite-like forms was investigated by direct observation using light microscopy of peripheral blood mononuclear cell (PBMC) suspensions obtained by gradient centrifugation (Isolymph, Gallard-Schlesinger, Cale Place, New York). Cytospin slides of PBMC were stained with WrighteGiemsa using an Ames HEMA-TEK slide stainer (Curtis Matheson Scientific, Houston, Texas). The images were recorded by a digital camera.
Detection of T gondii by immunofluorescence
A direct immunofluorescence assay designed by our group was used to detect the presence of T gondii in peripheral blood smears using polyclonal IgG antibody from T gondii-infected patients conjugated to fluorescein isothiocyanate (FITC). T gondii-specific IgG antibodies as well as the control were purified respectively from the pool of seropositive and seronegative T gondii serum by high-performance liquid chromatography (HPLC; ÄKTA Explorer, Amersham Pharmacia Biotech, Uppsala, Sweden) using a protein G affinity column (Amersham Pharmacia Biotech). FITC was conjugated with these antibodies as described by the manufacturer (Sigma, St Louis, Missouri). Smears of seronegative volunteers were used as negative controls. As positive controls, we incubated the smears of seronegative volunteers with RH T gondii strain (1:1) at 378C for 24 h. Controls and test smears were fixed with cold acetone for 30 min, blocked with PBS containing 2% BSA for 1 h at room temperature and incubated with an FITC-IgG anti-T gondii or FITC-IgG antibodies control at 378C for 1 h. Next, each sample was washed twice with PBS containing 2% BSA, a cover slide was added on the smear, and the fluorescence was observed using a Zeiss microscope (Carl Zeiss, New York). The images were captured by a digital camera (Nikon Coolpix 4500; Nikon, Tokyo).
Detection of T gondii by PCR
T gondii infections were confirmed by nested PCR amplification of the 5 9 end of the polymorphic marker of parasite SAG2 gene based on a protocol previously described. 17 The PCR mix for the nested reactions consisted of 75 mM Tris-HCl (pH 9.0), 50 mM KCl, 20 mM (NH 4 ) 2 SO 4 , 2 mM MgCl 2 , 0.001% bovine serum albumin, 200 mM each of the four deoxynucleoside triphosphates, 0.5 pmol of each primer, 1 U of DNA polymerase and, as a template, 1 to 20 ml of extracted sample DNA for the first reactions and 5 ml of a 1:100 dilution of the products of the first amplifications for the second reactions, in a final volume of 50 ml. All the PCRs were performed in a GeneAmp PCR System 9600 thermal cycler (Perkin-Elmer, Norwalk, Connecticut). The first step of amplification was 5 min of denaturation at 948C. This step was followed by 40 cycles, with 1 cycle consisting of 45 s at 948C, 45 s at the annealing temperature for each pair of primers and 60 s at 728C. The final cycle was followed by an extension step of 10 min at 728C. The amplification was performed using primers SAG2F4 and SAG2R4 in the first amplification, at an annealing temperature of 608C. In the second reaction, the internal primers SAG2F and SAG2R2 were used, with 588C as the annealing temperature. The final product of 241 bp was analysed in a 1.5% agarose gel electrophoresis. RH, Me49 and D7 strains of T gondii were used as positive controls.
Infection of immunodeficient mice with PBMC from patients
Four patients provided 100 000 PBMCs, obtained by gradient centrifugation as described earlier, which were injected in the peritoneal cavity of 6-week-old male athymic nude mice from the animal facility at the Biomedical Sciences Institute, University of São Paulo. Animals were followed and then sacrificed in a CO 2 chamber when a wasting syndrome started developing. Their brains and eyes were processed for histological examination upon H&E staining. Of the four patients from whom blood was drawn, one had acute infection with T gondii, and three had active recurrence of ocular toxoplasmosis. Blood from all 10 patients later included in the study was also used for this procedure.
RESULTS
Tachyzoite-like organisms were found in the blood samples of 16 patients. In samples from nine patients, organisms were detected using light microscopy (LM), whereas in seven the immunofluorescency assay (IF) was used (table 1). Figure 1 illustrates the result obtained with LM on cytospin slides of PBMC stained with WrighteGiemsa in which T gondiilike organisms can be recognised. The presence of the parasite on the peripheral blood of patients could also be determined by immunofluorescency ( figure 2A) , as was detected in the samples used as a positive control (figure 2B). No parasites were observed in the negative control (data not shown).
Either free tachyzoites and intracellular tachyzoites, or both, were observed by IF in peripheral blood smears from one of the two patients who had been recently infected (Group 1) (figure 1). LM (figure 2) detected free tachyzoites in the same patients. Seven of the eight chronically infected patients with recurrent retinochoroiditis (Group 2) had positive samples by IF, whereas one of them had a sample with no detectable parasite by LM. Of the three chronically infected individuals without retinal lesions (Group 4), one had a positive sample only by IF. In two cases, IF detected a positive signal, whereas LM did not. Because visual detection is somewhat subjected to interpretation, we investigated the presence of genetic material of T gondii in these samples by PCR. The isolation of DNA was carried out directly from the samples without previous isolation in either culture or mice. Amplification of 5 9 end of the SAG2 was successful in the three reference strains used in this study and in 11 of the 16 infected patients of the 18 clinical samples analysed (68.8%) (figure 3).
We were able to confirm the presence of the parasite by PCR in all positive sample detected by IF, except for one patient (patient 3). Conversely, three of the samples indicated as negative by both LM and IF were positive by PCR (patients 2, 13 and 16; table 1 figure 3 ). All six patients in group 2, and who entered in the study later were PCR positive, whereas all four individuals later included in group 3 were PCR-negative (data not shown). The patients from group 3 (IgG positive) with inactive lesions presented negative results in the IF and LM confirmed by PCR (table 1) . On the other hand, one patient was positive only to PCR (figure 3), raising the possibility that this specific patient may have few parasites or only parasite DNA circulating in the peripheral blood.
PBMCs from patients 1, 4, 7 and 10 were inoculated intraperitonealy in nude athymic mice, as described in the Methods. Animals were sacrificed and their brains prepared for histological examination. Figure 4 shows an example of the cyst observed in the brains of mice inoculated with each of the four samples. Blood from four out of six patients later included in group 2 also rendered cysts when inoculated in immunodeficient mice, whereas the blood of none of the four patients later included in group 3 resulted in recovered cysts.
DISCUSSION
In the course of our studies to understand the impact of the immune response against parasite antigens on susceptibility to ocular toxoplasmosis, we observed that the blood of some of the subjects evaluated contained tachyzoite-like organisms. In order to investigate the possibility that free parasites could be found in the blood of acute and chronically infected patients, we set up to study the first 20 individuals that came to the ophthalmic clinic in Erechim with complaints compatible with toxoplasmosis for those in a first visit, and those in follow-up visits already diagnosed as having toxoplasmosis.
Numerous isolates of T gondii from various specimens, including blood, 18 have been detected or obtained from immunocompromised patients, 19e21 but reports of parasite isolation from the blood of immunocompetent patients with toxoplasmosis are rare, and happen only soon after infection. 22 23 Tachyzoites have been isolated from the blood of immunocompetent patients with ocular disease 24 but not from the blood of patients with recurrent retinochoroiditis.
DNA of T gondii has been detected in almost 90% of the blood samples taken from patients with active toxoplasmic retinochoroiditis and in 50% of blood samples taken from patients with old toxoplasmic scars on the fundus. 25 26 In our study, we detected tachyzoites in the blood of patients with chronic infection and active ocular lesions, but not in the blood of patients without active lesions, which suggests that parasitaemia is associated with ongoing disease. The presence of tachyzoites in the blood of patients with recurrent disease supports the hypothesis that active parasites are important in the pathogenesis of ocular disease. This finding has important implications for treatment, as secondary prophylaxis may reduce the rate of recurrences in some patients. 27 This also explains the protective action of the association of sulfamethoxazole with trimetoprim to avoid recurrence, even though this drug combination is not effective against the parasite's cysts. 28 Recent evidence suggests that T gondii of the mixed genotypic clonal lineage is an important cause of ocular toxoplasmosis in the area of Erechim. 29 Type I parasites are known to be associated with increased virulence in animal models, and are suspected of being associated with more severe ocular disease in humans.
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In our study, we used a polyclonal serum against the parasite for the IF assay, instead of the available monoclonal antibodies, because of the unique nature of the T gondii strains seen in Brazil. 29 Such genetic uniqueness is associated with antigenic variation, with significant implications for antibody recognition (Rios LS et al, manuscript in preparation). Thus, the use of monoclonal antibodies would most certainly decrease the sensitivity of the test without enhancing its specificity. It is possible that parasitaemia reflects a more severe disease that is associated with these mixed type parasites. Our findings show that subclinical parasitaemia is present in acute and chronic toxoplasmosis patients, regardless of the presence of ocular lesions. This parasitaemia may be due to an infection reactivation in the eye. Alternatively, it may be caused by recurrent ocular lesions at different sites that have been reactivated or clinically unnoticed, or may even be due to reinfection.
A simple causality cannot be inferred from the simple observation of parasitaemia in the patients with active retinochorioditis. It is entirely possible that there is a higher prevalence of parasitaemia in patients with active retinochoroiditis because the parasitaemia results from retinochoroidal seeding, and not vice versa, since the vast majority of recurrences occur at or near the edge of existing lesions. Nevertheless, new lesions are recognised to occur distant from old scars, however, and the existence on ongoing parasitaemia in such patients might help explain such occurrences.
This study shows the presence of T gondii in peripheral blood of recently and chronically infected immunocompetent patients with or without ocular lesions. The observed parasitaemia in some patients may explain the dissemination of T gondii to remote sites in both immunocompetent individuals and in immunodepressed individuals. It also draws attention to the fact that in patients with active ocular lesions and positive antitoxoplasma IgG but negative IgM, propagation of the infection may still occur through the blood conferring a systemic character to the disease. The same mechanism may apply to toxoplasmic encephalitis in both immunocompetent and immunodepressed patients. Figure 3 Agarose gel electrophoresis analysis of the SAG2 PCR amplification product from patients with acute and chronic Toxoplasma gondii infection, and of seronegative volunteers (controls). Samples were prepared as described in the materials and methods section. Lanes 1 to 18 contain strains from peripheral blood of 18 patients as follows: lanes 1 and 2, group 1 (acute); lanes 3 to 10, group 2 (recurrence); lanes 11 to 13, group 3 (chronic); lanes 14 and 15, group 4 (non-ocular disease); lanes 16 to 18, group 5 (non-infection). Results are representative of 18 patients evaluated in this study. 
